enrotron 50 mg/ml solution for injection for cattle, pigs, dogs and cats
forte healthcare ltd - enrofloxacin - solution for injection - 50 milligram(s)/millilitre - enrofloxacin - cats, cattle, dogs, pigs - antibacterial
enrotron flavour 150 mg tablets for dogs
animedica gmbh - enrofloxacin - tablet - 150 milligram(s) - enrofloxacin - dogs - antibacterial
enrotron flavour 50 mg tablets for dogs
animedica gmbh - enrofloxacin - tablet - 50 mg/tablet - enrofloxacin - dogs - antibacterial
baytril® (enrofloxacin) antibacterial injectable solution 2.27% for dogs only
bayer healthcare llc animal health division - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn), butyl alcohol (unii: 8pj61p6ts3) (butyl alcohol - unii:8pj61p6ts3) - enrofloxacin 22.7 mg in 1 ml - baytril® (brand of enrofloxacin) injectable solution is indicated for the management of diseases in dogs associated with bacteria susceptible to enrofloxacin. efficacy confirmation: clinical efficacy was established in dermal infections (wounds and abscesses) associated with susceptible strains of escherichia coli , klebsiella pneumoniae , proteus mirabilis , and staphylococcus intermedius ; respiratory infections (pneumonia, tonsillitis, rhinitis) associated with susceptible strains of escherichia coli and staphylococcus aureus ; and urinary cystitis associated with susceptible strains of escherichia coli , proteus mirabilis , and staphylococcus aureus . enrofloxacin is contraindicated in dogs known to be hypersensitive to quinolones. based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in lar
baytril otic- enrofloxacin/silver sulfadiazine emulsion
bayer healthcare llc animal health division - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn), silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - enrofloxacin 5 mg in 1 ml - baytril® otic is indicated as a treatment for canine otitis externa complicated by bacterial and fungal organisms susceptible to enrofloxacin and/or silver sulfadiazine (see microbiology section). baytril® otic is contraindicated in dogs with suspected or known hypersensitivity to quinolones and/or sulfonamides.
centre-enrox 10% injection 100 mg/ml
aether centre (beijing) biology co., limited, china - enrofloxacin - injection - 100 mg/ml
enrofloxacin
dechra veterinary products (australia) pty. ltd. - enrofloxacin - unknown - enrofloxacin antibiotic active 0.0 - active constituent
enro 100 injectable solution
randlab australia pty ltd - enrofloxacin - enrofloxacin 100 g/litre - antibiotic
enrotron flavour 50 mg tablet
my vet care sdn bhd - enrofloxacin -
enro 50 mg/ml injection
headway investments pty ltd - enrofloxacin - parenteral liquid/solution/suspension - enrofloxacin antibiotic active 50.0 mg/ml - antibiotic & related